Walleye Capital LLC Astrazeneca PLC Put Options Transaction History

Walleye Capital LLC

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$66.81 - $80.83 $1.68 Million - $2.04 Million	-25,200 Reduced 10.54%	214,000 $16.7 Million
Q1 2024 May 15, 2024	SELL	$61.03 - $69.57 $811,699 - $925,280	-13,300 Reduced 5.27%	239,200 $16.2 Million
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $1.5 Million - $1.68 Million	24,200 Added 10.6%	252,500 $17 Million
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $7.79 Million - $8.61 Million	120,100 Added 111.0%	228,300 $15.5 Million
Q2 2023 Aug 14, 2023	BUY	$69.91 - $75.81 $5.26 Million - $5.71 Million	75,300 Added 228.88%	108,200 $7.74 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $1.09 Million - $1.24 Million	17,300 Added 110.9%	32,900 $2.28 Million
Q4 2022 Feb 14, 2023	SELL	$54.21 - $70.44 $102,999 - $133,836	-1,900 Reduced 10.86%	15,600 $1.06 Million
Q3 2022 Nov 14, 2022	BUY	$53.02 - $135.75 $927,850 - $2.38 Million	17,500 New	17,500 $960,000
Q2 2019 Aug 14, 2019	SELL	$37.28 - $41.68 $182,672 - $204,232	-4,900 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $88,725 - $107,550	-2,500 Reduced 33.78%	4,900 $198,000
Q3 2018 Nov 14, 2018	BUY	$34.76 - $39.72 $257,223 - $293,928	7,400 New	7,400 $293,000

1,343

492M

4.99M

3.19M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $233B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.